Skip to content

Bond™ PB0829

by Leica Biosystems Newcastle, Limited

Ref PB0829

Bond PB0829 is an in vitro diagnostic device (EU IVDD general IVD; FDA Class I; FDA product code MVU, Reagents, Specific, Analyte) made by Leica Biosystems Newcastle, Limited, registered in EUDAMED on 5 Jun 2026 (Basic UDI-DI B-05055331303486) and listed in FDA GUDID since 19 Mar 2021 (UDI-DI 05055331303486), active as of 22 Oct 2026.

Active European Union. Also listed in GUDID (US).

CE IVDD

Valid until

No date given

EUDAMED holds no validity date

FDA recalls

Not checked

No FDA submission to match recalls against

Documents

None linked in EUDAMED

A group certificate may exist

Trust

Unverified

Source EUDAMED, GUDID, synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
European UnionCE/IVDD EUDAMED NumberB-05055331303486 Basic UDI-DI 05055331303486UDI-DIDate5 Jun 2026RegisteredStatusActive
United StatesGUDID listing GUDID Number05055331303486 UDI-DI Date19 Mar 2021ListedStatusListed GUDID: in commercial distribution

Official records

From the FDA record

Device description
HPV Probe (Subtypes 16, 18, 31, 33, 51) is intended to be used for the qualitative identification of the Human Papillomavirus (HPV) DNA in formalin-fixed, paraffin-embedded tissue by in situ hybridization (ISH) using the automated BOND system (includes Leica BOND-MAX system and Leica BOND-III system). This probe binds to the five high risk HPV subtypes, 16, 18, 31, 33 and 51.
MRI safety
Labeling does not contain MRI Safety Information
Natural rubber latex
No latex statement on the label
Sterility
Supplied non-sterile

From the GUDID record (AccessGUDID), as read on 22 Oct 2026, as the labeller entered it.

Across registries

2 registries list this device

  • EUDAMED Basic UDI-DI B-05055331303486 registered 5 Jun 2026 Active
  • FDA GUDID UDI-DI 05055331303486 listed 19 Mar 2021 Listed

Timeline

2 dated events

  1. Listed FDA GUDID 05055331303486
  2. Registered EUDAMED B-05055331303486

Coverage

2 jurisdictions

United States of AmericaSwedenFinlandLatviaEstoniaDenmarkLithuaniaIrelandNetherlandsGermanyPolandFranceBelgiumLuxembourgCzech RepublicSlovakiaAustriaHungaryRomaniaSloveniaBulgariaPortugalSpainItalyCroatiaGreeceMaltaCyprus
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered
  • European Union CE/IVDD Active
  • United States GUDID listing Listed

Specification

EUDAMED · GUDID

Trade name
HPV Probe (subtypes 16, 18, 31, 33, 51) 6.25 mL EUDAMED
Bond™ GUDID
Generic name
Human papillomavirus (HPV) nucleic acid IVD, probe
Device name
BOND Ready-to-Use ISH HPV Probe (Subtypes 16, 18, 31, 33, 51)
Model / Ref / Catalog
PB0829
Primary DI / UDI-DI
05055331303486
Basic UDI-DI
B-05055331303486
FDA product code
MVU
EMDN code
W01030703 DNA in situ hybridisation reagents
GMDN term
Human papillomavirus (HPV) nucleic acid IVD, probe
Device class
Class IVD General EUDAMED
Class I GUDID
Regulation number
864.4020
EU registration type
Legacy device (under a directive)
EU market of registration
Germany
GUDID distribution status
In Commercial Distribution

Truth per registry

2 sources · 1 field differs

FieldEUDAMEDGUDID
Device classEUDAMED
Class IVD General
GUDID
Class I

Device class is stated on each registry's own scale: Class IVD General in the EU (EUDAMED), Class I in the US (FDA GUDID). EU and US classes are different schemes, so this is not a disagreement.

Similar devices in this category

Other devices filed under DNA IN SITU HYBRIDISATION REAGENTS.

Other devices from Leica Biosystems Newcastle, Limited

See all devices from Leica Biosystems Newcastle, Limited →

Properties

  • Contains animal tissues or cells
  • Contains substances of microbial origin
  • Reagent
  • Professional testing
  • Prescription use
  • Premarket exempt
  • Lot / batch number
  • Expiration date
Other properties (17, all answered No)